Relationship between postpartum infection and somatic pathology of the puerperant woman: a comparative analysis of comorbidity indices


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. The article presents modern data on the relationship between concomitant somatic pathology of pregnant women with maternal morbidity and the development of postpartum infectious complications. The terminological differences between the concepts of «comorbidity» and «polymorbidity» of concomitant pathology in the clinic of internal diseases and obstetric practice are discussed in detail. The main attention is paid to the role of primary extragenital diseases of a therapeutic profile in the development of postpartum infectious complications and methods for assessing comorbidity in pregnant women. Objective. Evaluation of comorbidity in puerperant women with endometritis after cesarean section (CS) and identification of an effective tool for its assessment for the subsequent stratification of patients into therapeutic groups with varying degrees of intensity of antimicrobial treatment. Methods. A retrospective study of 597 case histories of puerperant women delivered by CS surgery was carried out, of which 355 were diagnosed with endometritis after CS and 242 with the physiological course of the postoperative period. Results. Analysis of the data obtained showed that comorbidity is important for predicting the unfavorable course of endometritis after abdominal delivery. The Cumulative Illness Rating Scale (CIRS) has the best informational content, because it reflects the largest number of nosological forms in obstetric patients that affect the course of postpartum infection and its outcome. Conclusion. Among the comorbidity indices studied, the CIRS system correlates best with the severity of the course of endometritis after CS and the frequency of isolation of multiresistant pathogens determining an unfavorable prognosis of the disease and a high risk of failure when prescribing a standard scheme of empirical antimicrobial therapy.

Full Text

Restricted Access

About the authors

N. A Korobkov

North-Western State Medical University n.a. I.I. Mechnikov

Email: nikolai_korobkov@mail.ru
Cand. Sci. (Med.), Associate Professor at the Department of Obstetrics and Gynecology n.a. S.N. Davydov

N. V Bakulina

North-Western State Medical University n.a. I.I. Mechnikov

M. A Repina

North-Western State Medical University n.a. I.I. Mechnikov

References

  1. Репина М.А. Экстрагенитальные заболевания в структуре материнской смертности Санкт-Петербурга. Журнал акушерства и женских болезней. 2015;64(2):92-6
  2. Михалева Л.М. и др. Роль экстрагенитальной инфекционной патологии в структуре материнской смертности г. Москвы. Клиническая и экспериментальная морфология. 2020;9(3):34-42 doi: 10.31088/CEM2020.9.3.34- 42.
  3. Leonard S.A., et ai. An expanded obstetric comorbidity scoring system for predicting severe ma-ternal morbidity. Am J Obstet Gynecoi. 2020;136(3):440-49. Doi: 10.1097/ A0G.0000000000004022.
  4. Knight M., et ai. Beyond maternai death: improving the quaiity of maternai care through nationaistudies of «near-miss» maternai morbidity 2016;4(9):1-180. doi: 10.3310/pgfar04090.
  5. Rajbanshi S., Norhayati M.N., Nik Haziina N.H. High-risk pregnancies and their association with severe maternai morbidity in Nepai: A prospective cohort study. Pios ONE. 2020;15(12):e0244072. doi: 10.1371/journai.pone.0244072.
  6. McGregor J.C., et ai. Utiiity of the Chronic Disease Score and Charison Comorbidity index as comorbidity measures for use in epidemioiogic studies of antibiotic-resistant organisms. Am J. Epidemioi. 2005;161(5):483-93. Doi: 10.1093/ aje/lovi068i
  7. Kukiina E.V, et ai. Severe obstetric morbidity in the United States: 1998-2005. Am J Obstet Gynecoi. 2009;113(2):293-99. Doi: 10.1097/ A0G.0b013e3181954e5b.
  8. Feinstein A.R. The pre-therapeutic ciassification of co-morbidity in chronic disease. J Chron Dis. 19 70;23(7):455-68. doi: 10.1016/0021 - 9681(70)90054-8.
  9. Ведение беременности с экстрагенитальными заболеваниями. URL: https://ncagp.ru/index.php?_t8=255 (дата обращения/date accessed 17.05.2021).
  10. Оганов РГ. и др. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения. Кардиоваскулярная терапия и профилактика. 2019;18(1):5-66.
  11. Российская Федерация. Законы. Об основах охраны здоровья граждан в Российской Федерации: Федеральный закон №323-03: (принят Государственнойдумой 1 ноября 2011 г.: одобрен Советом Федерации 9 ноября 2011 г). М., 2012. Ст. 2, пункт 18 URL: http://www.consuitant.ru/ document/cons_doc_LAW_121895/b819c620 a8c698de35861ad4c9d9696ee0c3ee7a (дата обращения/date accessed: 17.05.2021).
  12. Верткин А.Л., Румянцев М.А., Скотников А.С. Коморбидность. Клиническая медицина. 2012;90(10):4-11
  13. Горин В.С. и др. Профилактика послеродовых гнойно-воспалительных заболеваний. Вопросы гинекологии, акушерства и перинатологии. 2011;10(1):67-74
  14. Somerviiie N.J., et ai. Obstetric Comorbidity and Severe Maternai Morbidity among Massachusetts Deiivery Hospitaiizations, 1998-2013. Matern Chiid Heaith J. 2019;23(9):1152-58. doi: 10.1007/s10995-019-02796-3
  15. Ei-Soih A.A., Grant B.J.B. A Comparison of Severity of iiiness Scoring Systems for Criticaiiy iii Obstetric Patients. Chest. 1996;110(5):1299-304. doi: 10.1378/chest.110.5.1299.
  16. Hazeigrove J.F., et ai. Muiticenter study of obstetric admissions to 14 intensive care units in southern Engiand. Criticai Care Med. 2001;29(4):770-75.
  17. Rojas-Suarez J., et ai. Comparison of severity-of-iiiness scores in criticaiiy iii obstetric patients: a 6-year retrospective cohort. Criticai Care Med. 2014;42(5):1047-54. Doi: 10.1097/ CCM.0000000000000124.
  18. Charison M., E. et ai. A new method of ciassifying prognostic comorbidity in iongitudinai studies: deveiopment and vaiidation. J Ciin. Epidemioi. 1987;40(5):373-83.
  19. Bateman B.T., Mhyre J.M, Hernandez-Diaz S., et ai. Deveiopment of a comorbidity index for use in obstetric patients. Am J Obstet Gynecoi. 2013;122(5):957-65. Doi: 10.1097/ AOG.0b013e3182a603bb.
  20. Aoyama K., D'Souza R., inada E., et ai. Measurement properties of comorbidity indices in maternai heaith research: a systematic review. BMC. Pregnancy Chiidbirth. 2017;17(1):372. doi: 10.1186/s12884-017-1558-3.
  21. Koiiuru V, Reddy A. Study of high risk scoring in pregnancy and perinatai outcome. indian J. Obstet. Gynecoi. Res. 2016;3(4):407-9.
  22. Easter S.R., et ai. Prospective ciinicai vaiidation of the obstetric comorbidity index for maternai risk assessment. Am J Obstet Gynecoi. 2019;220(1):S198-99. Doi: 10.1016/j. ajog.2018.11.299.
  23. Easter S.R., Bateman B.T., Sweeney V.H., et ai. A comorbidity-based screening tooi to predict severe maternai morbidity at the time of deiivery. Am J Obstet Gynecoi. 2019;221(3):271.e1-71.e10. doi: 10.1016/j.ajog.2019.06.025.
  24. Metcaife A., et ai. Vaiidation of an obstetric comorbidity index in an externai popuiation. BJOG: An internationai J Obstet Gynaecoi. 2015;122(13):1748-55. doi: 10.1111/14710528.13297.
  25. Fein A., Wen T, D'Alton M., et al. Risk factors and temporality for postpartum infection read-missions. Am J Obstet Gynecol. 2019;220(1):419-21. doi: 10.1016/j.ajog.2018.11.640.
  26. Fouly H, Abdou F.A, Abbas A.M. Audit for quality of care and fate of maternal critical cases at Women's Health Hospital. Appl Nursing Res. 2018;39:175-81. doi: 10.1016/j.apnr. 2017.11.003
  27. Черешнев В.А., Гусев Е.Ю, Юрченко Л.Н. Системное воспаление - миф или реальность? Вестник российской академии наук. 2004;74(3):219-27.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies